Cardiac Ablation Clinical Trials

Clinical trials related to Cardiac Ablation Procedure

The Value of Late Non-Invasive Programmed Stimulation (NIPS) in the Setting of Ventricular Tachycardia (VT) Ablation to Guide the Subsequent VT Therapeutic Strategies: a Prospective Randomized Multicenter Study

Status: Recruiting
Location: See location...
Intervention Type: Procedure, Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The aim of this study is to define the importance of non-invasive programmed stimulation (NIPS) in risk stratification of ventricular tachycardia (VT) recurrence after catheter ablation and to determine the optimal treatment strategy. The primary objective is to establish whether a new VT ablation based on NIPS inducibility will reduce the risk of VT recurrence compared to antiarrhythmic drug therapy.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients with an implanted ICD (all brands)

• Patients who underwent a successful (non-inducibility of any VT) Ventricular Tachycardia Ablation procedure, the index procedure, supported by EnSite Precision or CARTO 3D mapping systems for the following etiologies: previous MI, myocarditis, ARVD, IDCM.

• Induction of monomorphic VT at NIPS 3-7days after a successful index procedure

• Age 18 years or more

• Able to provide an informed consent to participate to the study and available to respect the assessments described in the protocol.

Locations
Other Locations
Italy
San Raffaele Hospital, Arrhythmology and Electrophysiology unit
RECRUITING
Milan
Contact Information
Primary
Andrea Radinovic, MD
radinovic.andrea@hsr.it
+39 0226436316
Backup
Anna Montagna, PhD
montagna.anna@hsr.it
+39 0226437489
Time Frame
Start Date: 2025-06-12
Estimated Completion Date: 2027-12
Participants
Target number of participants: 51
Treatments
Experimental: Group 1
AAD therapy
Experimental: Group 2
Re-Do ablation procedure
Sponsors
Leads: IRCCS Ospedale San Raffaele

This content was sourced from clinicaltrials.gov